U.S. Apheresis Equipment Market Size, Share & Trends Analysis Report By Product (Disposable Apheresis Kits, Device), By Application (Renal Disease, Neurology), By Procedure, By Technology, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Apheresis Equipment Market Growth & Trends
The U.S. apheresis equipment market size is anticipated to reach USD 1.64 billion by 2030, expanding at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Continuous improvements in apheresis technology have led to the development of more efficient, user-friendly, and cost-effective equipment. The rise in the prevalence of chronic diseases in the U.S., such as kidney failure, cancer, and autoimmune disorders, has led to a higher demand for apheresis procedures. For instance, according to the National Library of Medicine, in 2023, approximately 1,958,310 new cancer cases were observed in the U.S., that in turn, drives the need for apheresis equipment.
New product launches in the U.S. market bring innovative features and technological advancements to the equipment, improving their efficiency, accuracy, and performance. Regulatory approvals ensure that the apheresis equipment meets safety and efficacy standards, which is crucial for the end-users, such as hospitals and clinics. For instance, according to the Association for the Advancement of Blood & Biotherapies, in August 2023, Terumo BCT received its FDA clearance for its Reveous Automated Whole Blood Processing System. This boosts consumer confidence and contributes to the growth of the market.
U.S. Apheresis Equipment Market Report Highlights
U.S. Apheresis Equipment Market Growth & Trends
The U.S. apheresis equipment market size is anticipated to reach USD 1.64 billion by 2030, expanding at a CAGR of 8.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Continuous improvements in apheresis technology have led to the development of more efficient, user-friendly, and cost-effective equipment. The rise in the prevalence of chronic diseases in the U.S., such as kidney failure, cancer, and autoimmune disorders, has led to a higher demand for apheresis procedures. For instance, according to the National Library of Medicine, in 2023, approximately 1,958,310 new cancer cases were observed in the U.S., that in turn, drives the need for apheresis equipment.
New product launches in the U.S. market bring innovative features and technological advancements to the equipment, improving their efficiency, accuracy, and performance. Regulatory approvals ensure that the apheresis equipment meets safety and efficacy standards, which is crucial for the end-users, such as hospitals and clinics. For instance, according to the Association for the Advancement of Blood & Biotherapies, in August 2023, Terumo BCT received its FDA clearance for its Reveous Automated Whole Blood Processing System. This boosts consumer confidence and contributes to the growth of the market.
U.S. Apheresis Equipment Market Report Highlights
- Based on product, disposable apheresis kits dominated the market with more than 70% share in 2023 owing to the feature of eliminating the risk of cross-contamination and infection transmission between patients, as each kit is used only once and then discarded
- The device segment is expected to grow at the fastest CAGR over the forecast period
- Based on application, the neurology segment held the largest market share in 2023. Apheresis helps to remove the disease-causing antibodies or immune cells, thus reducing inflammation and protecting the nerves
- Market players operating in the U.S. apheresis equipment market include Haemonetics Corporation, Fresenius Kabi, B. Braun SE, Mallinckrodt Pharmaceuticals
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Procedure
1.2.4. Technology
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. Application
2.2.3. Procedure
2.2.4. Technology
2.3. Competitive Insights
CHAPTER 3. U.S. APHERESIS EQUIPMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Apheresis Equipment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. APHERESIS EQUIPMENT MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Apheresis Equipment Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Disposable Apheresis Kits
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Device
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. APHERESIS EQUIPMENT MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Apheresis Equipment Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Renal Disease
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Neurology
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hematology
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. U.S. APHERESIS EQUIPMENT MARKET: PROCEDURE ESTIMATES & TREND ANALYSIS
6.1. Procedure Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Apheresis Equipment Market by Procedure Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Photopheresis
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Plasmapheresis
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. LDL Apheresis
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Plateletpheresis
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Leukapheresis
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Erythrocytapheresis
6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others
6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. U.S. APHERESIS EQUIPMENT MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
7.1. Technology Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Apheresis Equipment Market by Technology Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Membrane Filtration
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. Centrifugation
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. U.S. APHERESIS EQUIPMENT MARKET: REGION ESTIMATES & TREND ANALYSIS
8.1. Regional Market Share, 2023 & 2030
8.2. U.S. Apheresis Equipment Market by Region Outlook
8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
8.3.1. West
8.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
8.3.2. Midwest
8.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.3.3. Northeast
8.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.3.4. Southwest
8.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.3.5. Southeast
8.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company heat map analysis, 2023
9.4. Company Profiles
9.4.1. Haemonetics Corporation
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Fresenius Kabi
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. B. Braun SE
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Mallinckrodt Pharmaceuticals
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Nikkiso Co., Ltd.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Asahi Kasei Medical Co., Ltd.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Terumo BCT
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Procedure
1.2.4. Technology
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. Application
2.2.3. Procedure
2.2.4. Technology
2.3. Competitive Insights
CHAPTER 3. U.S. APHERESIS EQUIPMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Apheresis Equipment Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. U.S. APHERESIS EQUIPMENT MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. Apheresis Equipment Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Disposable Apheresis Kits
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Device
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. U.S. APHERESIS EQUIPMENT MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. U.S. Apheresis Equipment Market by Application Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Renal Disease
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Neurology
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Hematology
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. U.S. APHERESIS EQUIPMENT MARKET: PROCEDURE ESTIMATES & TREND ANALYSIS
6.1. Procedure Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. U.S. Apheresis Equipment Market by Procedure Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Photopheresis
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Plasmapheresis
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. LDL Apheresis
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Plateletpheresis
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Leukapheresis
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Erythrocytapheresis
6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Others
6.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. U.S. APHERESIS EQUIPMENT MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
7.1. Technology Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. U.S. Apheresis Equipment Market by Technology Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Membrane Filtration
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. Centrifugation
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 8. U.S. APHERESIS EQUIPMENT MARKET: REGION ESTIMATES & TREND ANALYSIS
8.1. Regional Market Share, 2023 & 2030
8.2. U.S. Apheresis Equipment Market by Region Outlook
8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
8.3.1. West
8.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
8.3.2. Midwest
8.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.3.3. Northeast
8.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.3.4. Southwest
8.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.3.5. Southeast
8.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company heat map analysis, 2023
9.4. Company Profiles
9.4.1. Haemonetics Corporation
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Fresenius Kabi
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. B. Braun SE
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Mallinckrodt Pharmaceuticals
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Nikkiso Co., Ltd.
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Asahi Kasei Medical Co., Ltd.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Terumo BCT
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 U.S. apheresis equipment market, by product, 2018 - 2030 (USD Million)
Table 3 U.S. apheresis equipment market, by application, 2018 - 2030 (USD Million)
Table 4 U.S. apheresis equipment market, by procedure, 2018 - 2030 (USD Million)
Table 5 U.S. apheresis equipment market, by technology, 2018 - 2030 (USD Million)
Table 6 U.S. apheresis equipment market, by region, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 U.S. apheresis equipment market, by product, 2018 - 2030 (USD Million)
Table 3 U.S. apheresis equipment market, by application, 2018 - 2030 (USD Million)
Table 4 U.S. apheresis equipment market, by procedure, 2018 - 2030 (USD Million)
Table 5 U.S. apheresis equipment market, by technology, 2018 - 2030 (USD Million)
Table 6 U.S. apheresis equipment market, by region, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. apheresis equipment market: market outlook
Fig. 9 U.S. apheresis equipment competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. apheresis equipment market driver impact
Fig. 14 U.S. apheresis equipment market restraint impact
Fig. 15 U.S. apheresis equipment market: product movement analysis
Fig. 16 U.S. apheresis equipment market: product outlook and key takeaways
Fig. 17 Disposable apheresis kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Device estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 U.S. apheresis equipment market: application movement Analysis
Fig. 20 U.S. apheresis equipment market: application outlook and key takeaways
Fig. 21 Renal disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 U.S. apheresis equipment market: procedure movement analysis
Fig. 26 U.S. apheresis equipment market: procedure outlook and key takeaways
Fig. 27 Photopheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Plasmapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 LDL apheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Plateletpheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Erythrocytapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Other market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. apheresis equipment market: technology movement analysis
Fig. 35 U.S. apheresis equipment market: technology outlook and key takeaways
Fig. 36 Membrane filtration market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Centrifugation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 U.S. apheresis equipment market: regional movement analysis
Fig. 39 U.S. apheresis equipment market: regional outlook and key takeaways
Fig. 40 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. apheresis equipment market: market outlook
Fig. 9 U.S. apheresis equipment competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. apheresis equipment market driver impact
Fig. 14 U.S. apheresis equipment market restraint impact
Fig. 15 U.S. apheresis equipment market: product movement analysis
Fig. 16 U.S. apheresis equipment market: product outlook and key takeaways
Fig. 17 Disposable apheresis kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Device estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 U.S. apheresis equipment market: application movement Analysis
Fig. 20 U.S. apheresis equipment market: application outlook and key takeaways
Fig. 21 Renal disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 U.S. apheresis equipment market: procedure movement analysis
Fig. 26 U.S. apheresis equipment market: procedure outlook and key takeaways
Fig. 27 Photopheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Plasmapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 LDL apheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Plateletpheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Leukapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Erythrocytapheresis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Other market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 U.S. apheresis equipment market: technology movement analysis
Fig. 35 U.S. apheresis equipment market: technology outlook and key takeaways
Fig. 36 Membrane filtration market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Centrifugation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 U.S. apheresis equipment market: regional movement analysis
Fig. 39 U.S. apheresis equipment market: regional outlook and key takeaways
Fig. 40 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)
